Navigation Links
CV Therapeutics' Anti-Ischemic Agent Ranexa(R) Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI-36
Date:11/6/2007

s compared to placebo.

"The results of the MERLIN TIMI-36 study confirm that ranolazine is a safe and effective anti-ischemic drug that also has favorable effects on arrhythmia and HbA1c," Morrow said. "The reduction in HbA1c observed with ranolazine in the MERLIN TIMI-36 study is especially striking because the effects were observed on top of multiple other anti-diabetic drugs used as part of standard therapy."

In accordance with a special protocol assessment agreement between the U.S. Food and Drug Administration (FDA) and CV Therapeutics, the Company believes that data from the MERLIN TIMI-36 study could support expansion of the existing Ranexa indication to first line angina. In September 2007, the Company submitted a supplemental new drug application to the FDA seeking a new indication for first line angina and a significant reduction in cautionary language.

Ranexa is currently indicated for the treatment of chronic angina in patients who have not achieved an adequate response with other antianginal drugs, and should be used in combination with amlodipine, beta-blockers or nitrates.

Study Design

MERLIN TIMI-36 (Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes) was a multi-national, double-blind, randomized, placebo-controlled, parallel-group clinical trial designed to evaluate the efficacy and safety of Ranexa during acute and long-term treatment in 6,560 patients (3,279 received ranolazine, 3,281 received placebo) with non-ST elevation ACS treated with standard therapy.

Within 48 hours of the onset of angina due to ACS, eligible hospitalized patients were enrolled in the study and randomized to receive intravenous Ranexa or placebo, followed by long-term outpatient treatment with Ranexa extended-release tablets or placebo. All patients also received standard therapy during both hospital-based and outpatient treatment. The doses of Ranexa extended-release tablets used in MERL
'/>"/>

SOURCE CV Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... Md. , Aug. 27, 2015  BioElectronics Corporation (OTC ... announced today that three abstracts featuring the use of ... at the 9 th Congress of the European ... 2-5 th September 2015. The Company will also ... Dr Gianluca Bagnato , department clinical and ...
(Date:8/27/2015)... 27, 2015  PinnacleHealth CardioVascular Institute enrolled the first patient ... the United States in a trial assessing ... for blockages in the main artery of the leg. The ... potentially less risk for stent fracture or re-narrowing after the ... multicenter clinical trial of the BioMimics 3D Stent System and ...
(Date:8/27/2015)... , Aug. 27, 2015   Americord Registry ... tissue , and placenta tissue banking company, ... blood banking e-commerce website. This new website makes the ... with an interactive shopping cart and checkout process. ... "Most cord blood banking websites make this service difficult ...
Breaking Medicine Technology:BioElectronics Selected to Present its Pain Research and Devices at the European Pain Federation Conference 2First Pennsylvania Patient Treated in Landmark Vascular Study 2Cord Blood Bank Revolutionizes Process of Online Cord Blood Banking 2
(Date:8/27/2015)... ... August 28, 2015 , ... Shortening the school week to ... mathematics, according to researchers at Georgia State University and Montana State University. , ... the impact of a four-day school week on student achievement by comparing fourth-grade ...
(Date:8/27/2015)... Clearwater, Florida (PRWEB) , ... August 28, 2015 , ... ... process to ensure that patients are always scheduled for the next visit, their authorizations ... it here . , According to Jason Barnes, COO for Genesis Chiropractic Software, ...
(Date:8/27/2015)... ... ... Mesa Community College graduate, Andrew Sypher (Mesa), is one of ... leadership and engagement, to receive a Phi Theta Kappa 2015 Hites Transfer Scholarship, to ... and a $7,500 scholarship to assist in his goal of becoming a foreign diplomat ...
(Date:8/27/2015)... ... August 27, 2015 , ... Workflow in labs ... PCR (qPCR) in the last decade. New features such as multiplexing, microfluidics, ... the flipside, where do lab managers, technicians, and researchers find handy metrics to ...
(Date:8/27/2015)... Denver, CO (PRWEB) , ... August 27, 2015 , ... ... author examined the current policing situation in the city of New Orleans, highlighting a ... Force, the firm is run by a tech oriented entrepreneur who worked with the ...
Breaking Medicine News(10 mins):Health News:Four-Day School Week Can Improve Academic Performance, Study Finds 2Health News:Four-Day School Week Can Improve Academic Performance, Study Finds 3Health News:A New Webinar Teaches Chiropractors How to Use Compliance Alerts to Manage Patient Relationships 2Health News:Mesa Community College Graduate Andrew Sypher Receives Hites Transfer Scholarship 2Health News:Mesa Community College Graduate Andrew Sypher Receives Hites Transfer Scholarship 3Health News:Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments 2Health News:Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments 3Health News:Article on New Orleans Security Force Highlights the Abilities and Flexibility of Private Security, says Spear Security Inc. 2
... 4 The Association for Community Affiliated Plans ... and CareOregon come together to present the unique ... benefited by Medicaid Managed Care and Safety Net ... renowned American photographer who has dedicated his life ...
... manufacturer of industrial parts cleaning systems and custom metal fabrication ... Midbrook’s Cart Washer for Central Processing was recently installed ... Processing is a large capacity, fully automated, floor loading cleaning ... of hospitals. , ...
... A new website that displays a wealth of information about the ... maps reveals a few surprises. , ... Washington, DC ... application that displays a wide variety of information about the fifty ...
... cost of methamphetamine use in the United States reached ... premature death, drug treatment and many other aspects of ... , The RAND study is the first effort to ... the methamphetamine problem in the United States. , "Our ...
... Level on Certain Products Expanded to Retail LevelST. LOUIS, Feb. ... (NYSE: KVa ; KVb), is issuing a ... recall on certain products. The recall on the products ... but is now being expanded to the retail level. ...
... Feb. 3 Companies that manufacture products containing ... product stewardship measures to limit potential liability exposure ... Klapper and James Wood.This issue will be thoroughly ... Law, Regulation and Policy, February 18-19, 2009, in ...
Cached Medicine News:Health News:Pictures Say a Thousand Words... No American Should Lack Access to Affordable, Comprehensive Health Services 2Health News:Midbrook Installs New Cart Washer for Central Processing in Local Hospital 2Health News:SHOWUSA Launches: New Website Showcases Animated Maps of U.S. Facts and Figures 2Health News:Methamphetamine use cost the US about $23 billion in 2005, RAND study estimates 2Health News:Methamphetamine use cost the US about $23 billion in 2005, RAND study estimates 3Health News:ETHEX Corporation Issues Voluntary Nationwide Recall 2Health News:Risk-Management Policies Needed Now in Nanotechnology, Insighter Piece Concludes; FDLI Sponsors Nanotechnology Meeting, Publishes Book on FDA-Regulated Products 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: